1. Home
  2. ENOV vs SID Comparison

ENOV vs SID Comparison

Compare ENOV & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • SID
  • Stock Information
  • Founded
  • ENOV 1995
  • SID 1941
  • Country
  • ENOV United States
  • SID Brazil
  • Employees
  • ENOV N/A
  • SID N/A
  • Industry
  • ENOV Fluid Controls
  • SID Steel/Iron Ore
  • Sector
  • ENOV Industrials
  • SID Industrials
  • Exchange
  • ENOV Nasdaq
  • SID Nasdaq
  • Market Cap
  • ENOV 2.1B
  • SID 2.0B
  • IPO Year
  • ENOV 2008
  • SID 1997
  • Fundamental
  • Price
  • ENOV $35.09
  • SID $1.69
  • Analyst Decision
  • ENOV Buy
  • SID Strong Sell
  • Analyst Count
  • ENOV 4
  • SID 1
  • Target Price
  • ENOV $58.50
  • SID $1.30
  • AVG Volume (30 Days)
  • ENOV 999.2K
  • SID 2.0M
  • Earning Date
  • ENOV 05-08-2025
  • SID 05-05-2025
  • Dividend Yield
  • ENOV N/A
  • SID 13.18%
  • EPS Growth
  • ENOV N/A
  • SID N/A
  • EPS
  • ENOV N/A
  • SID N/A
  • Revenue
  • ENOV $2,107,623,000.00
  • SID $7,063,567,739.00
  • Revenue This Year
  • ENOV $7.13
  • SID $7.06
  • Revenue Next Year
  • ENOV $6.33
  • SID $3.65
  • P/E Ratio
  • ENOV N/A
  • SID N/A
  • Revenue Growth
  • ENOV 23.45
  • SID N/A
  • 52 Week Low
  • ENOV $29.32
  • SID $1.27
  • 52 Week High
  • ENOV $56.43
  • SID $2.89
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 51.27
  • SID 59.55
  • Support Level
  • ENOV $30.68
  • SID $1.46
  • Resistance Level
  • ENOV $35.63
  • SID $1.56
  • Average True Range (ATR)
  • ENOV 2.06
  • SID 0.08
  • MACD
  • ENOV 0.52
  • SID 0.02
  • Stochastic Oscillator
  • ENOV 91.44
  • SID 97.47

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: